STAAR Surgical Debt to Equity Ratio 2010-2024 | STAA
Current and historical debt to equity ratio values for STAAR Surgical (STAA) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. STAAR Surgical debt/equity for the three months ending December 31, 2024 was 0.00.
| STAAR Surgical Debt/Equity Ratio Historical Data |
| Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
| 2024-12-31 |
$0.11B |
$0.40B |
0.28 |
| 2024-09-30 |
$0.11B |
$0.43B |
0.26 |
| 2024-06-30 |
$0.10B |
$0.41B |
0.25 |
| 2024-03-31 |
$0.10B |
$0.39B |
0.25 |
| 2023-12-31 |
$0.10B |
$0.39B |
0.27 |
| 2023-09-30 |
$0.09B |
$0.38B |
0.25 |
| 2023-06-30 |
$0.09B |
$0.35B |
0.25 |
| 2023-03-31 |
$0.08B |
$0.34B |
0.24 |
| 2022-12-31 |
$0.08B |
$0.34B |
0.25 |
| 2022-09-30 |
$0.08B |
$0.32B |
0.23 |
| 2022-06-30 |
$0.08B |
$0.30B |
0.26 |
| 2022-03-31 |
$0.08B |
$0.28B |
0.27 |
| 2021-12-31 |
$0.09B |
$0.26B |
0.34 |
| 2021-09-30 |
$0.08B |
$0.25B |
0.30 |
| 2021-06-30 |
$0.06B |
$0.24B |
0.26 |
| 2021-03-31 |
$0.05B |
$0.21B |
0.24 |
| 2020-12-31 |
$0.06B |
$0.20B |
0.31 |
| 2020-09-30 |
$0.05B |
$0.19B |
0.26 |
| 2020-06-30 |
$0.04B |
$0.18B |
0.25 |
| 2020-03-31 |
$0.04B |
$0.17B |
0.25 |
| 2019-12-31 |
$0.05B |
$0.16B |
0.30 |
| 2019-09-30 |
$0.04B |
$0.15B |
0.29 |
| 2019-06-30 |
$0.04B |
$0.14B |
0.29 |
| 2019-03-31 |
$0.04B |
$0.14B |
0.29 |
| 2018-12-31 |
$0.04B |
$0.13B |
0.26 |
| 2018-09-30 |
$0.03B |
$0.13B |
0.27 |
| 2018-06-30 |
$0.03B |
$0.05B |
0.62 |
| 2018-03-31 |
$0.03B |
$0.05B |
0.71 |
| 2017-12-31 |
$0.03B |
$0.04B |
0.58 |
| 2017-09-30 |
$0.03B |
$0.04B |
0.79 |
| 2017-06-30 |
$0.03B |
$0.04B |
0.66 |
| 2017-03-31 |
$0.03B |
$0.04B |
0.77 |
| 2016-12-31 |
$0.03B |
$0.04B |
0.73 |
| 2016-09-30 |
$0.03B |
$0.04B |
0.76 |
| 2016-06-30 |
$0.03B |
$0.04B |
0.72 |
| 2016-03-31 |
$0.02B |
$0.04B |
0.61 |
| 2015-12-31 |
$0.02B |
$0.04B |
0.62 |
| 2015-09-30 |
$0.02B |
$0.04B |
0.57 |
| 2015-06-30 |
$0.02B |
$0.04B |
0.52 |
| 2015-03-31 |
$0.02B |
$0.04B |
0.56 |
| 2014-12-31 |
$0.02B |
$0.04B |
0.59 |
| 2014-09-30 |
$0.02B |
$0.04B |
0.55 |
| 2014-06-30 |
$0.02B |
$0.04B |
0.54 |
| 2014-03-31 |
$0.02B |
$0.04B |
0.56 |
| 2013-12-31 |
$0.02B |
$0.04B |
0.59 |
| 2013-09-30 |
$0.02B |
$0.04B |
0.57 |
| 2013-06-30 |
$0.02B |
$0.04B |
0.58 |
| 2013-03-31 |
$0.02B |
$0.03B |
0.61 |
| 2012-12-31 |
$0.02B |
$0.03B |
0.73 |
| 2012-09-30 |
$0.02B |
$0.03B |
0.59 |
| 2012-06-30 |
$0.02B |
$0.03B |
0.58 |
| 2012-03-31 |
$0.02B |
$0.03B |
0.58 |
| 2011-12-31 |
$0.02B |
$0.03B |
0.66 |
| 2011-09-30 |
$0.02B |
$0.03B |
0.62 |
| 2011-06-30 |
$0.02B |
$0.03B |
0.67 |
| 2011-03-31 |
$0.02B |
$0.02B |
0.72 |
| 2010-12-31 |
$0.02B |
$0.02B |
0.81 |
| 2010-09-30 |
$0.02B |
$0.02B |
0.78 |
| 2010-06-30 |
$0.02B |
$0.02B |
0.72 |
| 2010-03-31 |
$0.03B |
$0.02B |
1.41 |
| 2009-12-31 |
$0.04B |
$0.02B |
1.79 |
| 2009-09-30 |
$0.04B |
$0.02B |
1.64 |
| 2009-06-30 |
$0.04B |
$0.02B |
1.55 |
| 2009-03-31 |
$0.04B |
$0.01B |
2.46 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED/DENTAL-SUPP |
$0.942B |
$0.314B |
|
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
|
